CytomX Therapeutics (CTMX) Operating Margin (2014 - 2026)
CytomX Therapeutics (CTMX) operating margin from Sep 30, 2014 to Mar 31, 2026. The current CytomX Therapeutics (CTMX) operating margin is -191.72%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of CytomX Therapeutics (CTMX)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -29.34% | -262.10% |
| 2024 | 18.10% | -382.74% |
| 2023 | -6.40% | -96.64% |
| 2022 | -190.61% | -38.71% |
| 2021 | -311.02% | -0.81% |
| 2021 | -313.57% | -7.16% |
| 2021 | -337.76% | +11.32% |
| 2021 | -303.41% | +6.32% |
| 2021 | -285.37% | +489.29% |
| 2020 | -48.43% | -58.86% |
| 2020 | -117.70% | -65.14% |
| 2020 | -337.62% | -8.39% |
| 2020 | -368.53% | +3048.25% |
| 2020 | -11.71% | -99.13% |
| 2019 | -1339.25% | +154.64% |
| 2019 | -525.95% | +301.87% |
| 2018 | -130.87% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | -64.59% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | -100.00% |
| 2016 | -463.74% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | -100.00% |
| 2015 | -430.61% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | -100.00% |
| 2014 | -585.83% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | -100.00% |
| 2013 | -1680.90% | N/A |
Comparison CytomX Therapeutics (CTMX) operating margin with competitors
CytomX Therapeutics (CTMX) operating margin is -191.72%.